Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - SEELOS THERAPEUTICS, INC. | v234096_ex99-1.htm |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 2, 2011
Apricus Biosciences, Inc.
(Exact name of registrant as specified in its charter)
|
Nevada
|
0-22245
|
87-0449967
|
||
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
|
6330 Nancy Ridge Drive, Suite 103, San Diego, California
|
92121
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (858) 222-8041
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
On September 2, 2011, Apricus Biosciences, Inc. issued a press release correcting the terminology relating to its over-the-counter products. A copy of the release is attached hereto as Exhibit 99.1.
(d) Exhibits. The following exhibit is filed with this report on Form 8-K:
|
|
||
|
Exhibit Number
|
Description of Exhibit
|
|
|
99.1
|
Press Release, dated September 2, 2011.
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
September 2, 2011
|
Apricus Biosciences, Inc.
|
|||
|
By:
|
/s/ Randy Berholtz
|
|||
|
Randy Berholtz
|
||||
|
Executive Vice President, General Counsel and Secretary
|
||||
|
Exhibit Number
|
Description of Exhibit
|
|
|
99.1
|
Press Release, dated September 2, 2011.
|